The 3D modelling technology developer is reportedly looking to raise additional growth funding after collecting $48m in a Qualcomm-backed round.

Fitz Gate Ventures has started raising the successor to its initial $10m fund mainly focused on spinouts and startups linked to Princeton University.

Contrary Capital is seeding a second vehicle to back spinouts and university-linked startups through venture partners based at faculties across the US.

Commercial partner Sirius has reinvested in the worker's compensation insurance startup as part of a series B round that will fund geographic growth.

Intel Capital and Mitsui participated in a $33m series C round for Fictiv, boosting the contract manufacturing platform's overall funding to $58m.

Alicia Irurzun-Lafitte has departed from a principal position at M Ventures for a partner role at another pharmaceutical firm's corporate venturing fund, UCB Ventures.

GV participated as a new investor, as Harvard's genetic medicine developer Beam Therapeutics completed a round that followed $87m in series A funding last year.

GV participated as a new investor, as genetic medicine developer Beam Therapeutics completed a round that followed $87m in series A funding last year.

The rechargeable hearing aid producer has now raised more than $144m altogether, having collected about $52m in a series D round featuring Nan Fung Life Sciences.

Blue Cross of Idaho was among the investors in a series B round that took the healthcare analytics platform operator's overall funding to more than $26m